Vitadio develops AI-driven digital therapeutics for type 2 diabetes, utilizing real-time feedback and personalized lifestyle modification to reverse insulin resistance. The platform enables users to achieve significant reductions in HbA1c and body weight, improving diabetes management without the side effects associated with traditional medications.
Funding
$3.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Type 2 diabetes management often relies on medication, which can have side effects and may not address the underlying issue of insulin resistance. Traditional lifestyle interventions can be difficult to implement and sustain, leading to suboptimal outcomes for patients.
Solution
Vitadio offers a prescription digital therapeutic (PDT) that uses AI-driven personalized lifestyle modification to help reverse insulin resistance in individuals with type 2 diabetes and prediabetes. The platform delivers real-time diet feedback, personalized goals, and smart nudges to build healthy habits. Users also have access to proactive human support, including an in-app social network and personal dietitians. The program aims to achieve significant reductions in HbA1c levels and body weight without the side effects associated with traditional medications.
Target Audience
The primary target audience includes individuals with type 2 diabetes and prediabetes, as well as healthcare providers and statutory health insurers seeking effective and accessible digital therapeutics.
Features
- AI-powered real-time diet feedback and recommendations
- Personalized therapy plans based on user data and evidence-based content
- Proactive human support via in-app social network and personal dietitians
- Integration of smart nudges and personalized goals to promote healthy habit formation
- Clinical validation demonstrating comparable efficacy to antidiabetic drugs
- Class I medical device under MDR
- ISO 27001 and GDPR compliant